References
- Pharmaceutical Manufacturers Association. Drusafe Subsection, The September/1980 Guidelines
- Smyth R. D., Hottendorf G. H. Application of pharmacokinetics and biopharmaceutics in the design of toxicological studies. Toxicol. Appl. Pharmacol. 1980; 53: 179–195
- Burstein C. L. Utility of intravenous procaine in the anesthetic management of cardiac disturbances. Anesthesiology 1949; 10: 133–144
- Drayer D. E., Reidenberg M. M., Sevy R. W. N-Acetylprocainamide: An active metabolite of procainamide. Proc. Soc. Exp. Biol. Med. 1974; 146: 358–363
- Elson J., Strong J. M., Lee W. K., Atkinson A. J., Jr. Antiarrhythmic potency of N-acetylprocainamide. Clin. Pharmacol. Ther. 1975; 17: 134–140
- 'Kosowsky B. D., Taylor J., Lown B., Ritchie R. F. Long-term use of procainamide following acute myocardial infarction. Circulation 1973; 47: 1204–1210
- Stec G. P., Ruo T. I., Thenot J. P., Atkinson A. J., Jr., Morita Y., Lertora J. L. Kinetics of N-acetylprocain-amide deacetylation. Clin. Pharmacol. Ther. 1980; 28: 659–666
- Kamath B. L., Lai C. M., Gupta S. D., Durrani M. J., Yacobi A. Pharmacokinetics of procainamide and N-acetylprocainamide in rats. J. Pharm. Sci. 1981; 70: 299–302
- Reidenberg M. M., Drayer D. E., Levy M., Warner H. Polymorphic acetylation of procainamide in man. Clin. Pharmacol. Ther. 1975; 17: 722–730
- Lai C. M., Kamath B. L., Look Z. M., Yacobi A. Determination of procainamide and N-acetylprocainamide in biological fluids by high-pressure liquid chromatography. J. Pharm. Sci 1980; 69: 982–984
- Yacobi A., Stampfli H. F., Lai C. M., Kamath B. L. Tissue distribution of N-acetylprocainamide in rats. Drug Met. Dispos 1981; 9: 193–195
- Kamath B. L., Yacobi A., Gupta S. D., Stampfli H. F., Durrani M., Lai C. M. Bioavailability of N-acetylprocainamide from mixed diet in rats. Res. Commun. Chem. Path. Pharmacol. 1981; 32: 299–308
- Ding T. L., Lin E. T., Benet L. Z. The reversible biotransformation of N-acetylprocainamide in the rhesus monkey. Arzneim.-Forsch. 1978; 28: 281–283
- Schneck D. W., Grove K., Dewitt F. O., Shiroff R. A., Hayes A. H., Jr. The quantitative disposition of procainamide and N-acetylprocainamide in the rat. J. Pharmacol. Exp. Ther 1978; 204: 219–225
- Strong J. M., Dutcher J. S., Lee W. K., Atkinson A. J., Jr. Absolute bioavailability in man of N-acetylprocainamide determined by a novel stable isotope method. Clin. Pharmacol. Ther. 1975; 18: 613–622
- Gibaldi M., Perrier D. Drugs and the Pharmaceutical Sciences, Pharmacokinetics. Dekker, New York 1975; vol. 1
- Kamath B. L., Yacobi A. Half-life of N-acetylprocainamide in rats. J. Pharm. Sci. 1980; 69: 864–865
- Koch-Weser J. Pharmacokinetics of procainamide in man. Ann. N.Y. Acad. Sci. 1971; 179: 370–382
- Strong J. M., Dutcher J. S., Lee W. K., Atkinson A. J., Jr. Pharmacokinetics in man of the N-acetyl -ated metabolite of procainamide. J. Pharmacokinet. Biopharm. 1975; 3: 223–235
- Renkin E. M., Gilmore J. P. Handbook of Physiology, sec. 8: Renal Physiology, J. Orloff, R. W. Berliner, S. R. Geiger. American Physiology Society, Washington, D.C. 1973; 185–248
- Carter J. E., Dutcher J. S., Carney D. P., Klein L. R., Black L. A., Erhardt P. W. Analysis of procainamide hydrochloride and acecainide hydrochloride in rat feed, J. Pharm. Sci. 1980; 69: 1439–1440
- Wang L. Plasma volume, cell volume, total blood volume and F cell factor in the normal and splenectomized Sherman rat. Am. J. Physiol. 1959; 196: 188–192
- Kamath B. L., Lai C. M., Krasula R. W., Stampfli H. F., Gupta S. D., Yacobi A. Disposition study of procainamide and N-acetylprocainamide during subacute administration in rats. Toxicol. Appl. Pharmacol. 1982; 62: 158–166
- Atkinson A. J., Jr., Lee W. K., Quinn M. L., Kushner W., Nevin M. J., Strong J. M. Dose ranging trial of N-acetylprocainamide in patients with premature ventricular contractions. Clin. Pharmacol. Ther 1977; 21: 575–585
- Yacobi A., Krasula R. W., Lai C. M., Kamath B. L. Effective plasma concentration of N-acetylprocainamide in rats. Res. Commun. Chem. Path. Pharmacol. 1979; 24: 197–200
- Koch-Weser J., Klein S. W. Procainamide dosage schedules, plasma concentrations and clinical effects. J. Am. Med. Assoc 1971; 215: 1454–1460
- Davies D. F., Shock N. W. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J. Clin. Invest. 1950; 29: 496–507
- Friedman S. A., Raizner A. E., Rosen H., Solomon N. A., Sy W. Functional defects in the aging kidney. Ann. Intern. Med. 1972; 76: 41–45
- Yates M. S., Hiley C. R. The effect of age on cardiac output and its distribution in the rat. Experientia 1979; 35: 78–79